Lisa Henderson

Influenced by lessons from the playing field, former rugby athlete James Robinson, today president and CEO of Urovant Sciences, discusses the keys to establishing a high-performing team culture in biopharma—and the end-game wins in treatment gain and patient need.

Recent roundtable highlights need for biopharma to enter ESG conversation.

Past lessons, strong resolve, and complex coordination propel J&J’s vaccine efforts.